Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07159100 · ClinicalTrials.gov registry record · Early Phase 1
tDCS for Cancer-Related Fatigue and Weakness
A Early Phase 1 study, sponsored by Kessler Foundation.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 75
- Enrollment target
NCT07159100: Clinical Trial Early Phase 1 study, sponsored by Kessler Foundation.
NCT07159100 is a Early Phase 1 study that has not yet begun recruiting, run by Kessler Foundation. The registered enrollment target is 75 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (42% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07159100, a Early Phase 1 study, has not yet begun recruiting, sponsored by Kessler Foundation.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 75 participants
- Enrollment target
Study Summary
This pilot study investigates the effectiveness of non-invasive brain stimulation (tDCS) in alleviating cancer-related fatigue (CRF) and muscle weakness. Using a randomized, double-blind crossover design, participants perform fatiguing muscle tasks with and without tDCS, and outcomes include task endurance, maximal voluntary contraction force, and neuromuscular markers. Neural mechanisms will be assessed via EEG, TMS, and MRI.
Primary Outcome
Duration (in seconds) that participants are able to maintain a submaximal isometric contraction (20-40% of maximal voluntary contraction) during a fatigue-inducing task, performed with and without transcranial direct current stimulation (tDCS).
Interventions
- DEVICE Active tDCS + elbow flexion exercise
- DRUG Sham tDCS + elbow flexion exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-09-10 |
| Est. Completion | 2027-12-31 |
| Phase | Early Phase 1 |
What is known before NCT07159100 opens enrollment
NCT07159100 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (42% higher).
The record links to 0 conditions, and to 2 interventions - of which Active tDCS + elbow flexion exercise is the first listed.
NCT07159100 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07159100 about?
NCT07159100 is a clinical study titled "tDCS for Cancer-Related Fatigue and Weakness". This pilot study investigates the effectiveness of non-invasive brain stimulation (tDCS) in alleviating cancer-related fatigue (CRF) and muscle weakness. Using a randomized, double-blind crossover design, participants perform fatiguing muscle tasks with and without tDCS, and outcomes include task en...
What is the current status of trial NCT07159100?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 75 participants. The study started on 2025-09-10. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07159100?
The interventions under investigation include: Active tDCS + elbow flexion exercise (DEVICE), Sham tDCS + elbow flexion exercise (DRUG).
Who is sponsoring clinical trial NCT07159100?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07159100's enrollment target sits among peer trials
75 304th of 2000 higher than 1,689 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI